dr. jacobson on design of zuma-5 trial in r/r indolent non-hodgkin lymphoma
Published 4 years ago • 147 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:09
dr. jacobson on the zuma-5 trial with axi-cel in high-risk relapsed/refractory inhl
-
4:51
zuma-5: axi-cel for r/r non-hodgkin lymphoma
-
0:57
dr. jacobson on the benefit of axi-cel in relapsed/refractory follicular lymphoma
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
2:46
advances in lymphoma: a patient's journey
-
8:17
novel agents and combinations in hodgkin lymphoma
-
3:18
zuma-5: axi-cel for r/r inhl
-
23:39
cell sensitivity (law of bergonie and tribondeau) and radiation response curves
-
30:04
yunhe li: segmentation of lymphoma in pet/ct images
-
2:17
zuma-12: axicabtagene ciloleucel as a first-line therapy in patients with high-risk lbcl
-
3:46
zuma-5 update: retreatment of r/r inhl with axi-cel
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
2:01
lymphoma cell sensitivity study by neutrophil analysis | protocol preview
-
1:15
primary overall survival analysis of the zuma-7 trial
-
1:10:38
car t-cell therapy in high-risk non-hodgkin lymphoma
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
9:38
types of lymphoma with associate professor jake shortt
-
0:32
diagnosis of lymphoma
-
1:26
processing an advanced hodgkin lymphoma diagnosis
-
7:52
hodgkin’s lymphoma (hodgkin disease) - quick review - hematology and oncology series